Get the Stockscreener App
20.00
0.20%
-0.04
Stevanato Group Spa stock is traded at $20.00, with a volume of 358.06K.
It is down -0.20% in the last 24 hours and up +15.81% over the past month.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
See More
Previous Close:
$20.04
Open:
$19.94
24h Volume:
358.06K
Relative Volume:
0.66
Market Cap:
$5.47B
Revenue:
$1.18B
Net Income/Loss:
$132.61M
P/E Ratio:
33.53
EPS:
0.5964
Net Cash Flow:
$-276.17M
1W Performance:
+9.47%
1M Performance:
+15.81%
6M Performance:
+0.15%
1Y Performance:
-23.02%
1-Day Range:
$19.49
$20.15
1-Week Range:
$18.17
$20.35
52-Week Range:
$16.56
$34.73
Stevanato Group Spa Stock (STVN) Company Profile
Name
Stevanato Group Spa
Sector
Industry
Phone
-
Address
-
Compare STVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STVN
Stevanato Group Spa
|
20.00 | 5.47B | 1.18B | 132.61M | -276.17M | 0.5964 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-22-24 | Initiated | Exane BNP Paribas | Outperform |
| Nov-01-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-26-23 | Initiated | Stephens | Overweight |
| Sep-19-23 | Initiated | CJS Securities | Market Outperform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-10-21 | Initiated | BofA Securities | Buy |
| Aug-10-21 | Initiated | Citigroup | Buy |
| Aug-10-21 | Initiated | Jefferies | Buy |
| Aug-10-21 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-10-21 | Initiated | Morgan Stanley | Overweight |
| Aug-10-21 | Initiated | Wells Fargo | Overweight |
View All
Stevanato Group Spa Stock (STVN) Latest News
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On - GuruFocus.com
Stevanato Group (NYSE:STVN) vs. Todos Medical (OTCMKTS:TOMDF) Financial Contrast - Defense World
Stevanato Group (NYSE:STVN) Stock Price Down 0.4%Here's Why - MarketBeat
Objective long/short (STVN) Report - Stock Traders Daily
Frank Sands Reduces Stake in Stevanato Group SpA - GuruFocus.com
Stevanato S p A : 2R Vials and Deep Cold StorageDetermining Mechanical & CCI performances - Marketscreener.com
Significant Acquisition by T. Rowe Price Investment Management i - GuruFocus.com
Pharmaceutical Visual Inspection Systems Market Report: - openPR
Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement - Seeking Alpha
Stevanato Group's (NYSE:STVN) Anemic Earnings Might Be Worse Than You Think - Simply Wall St
Earnings Troubles May Signal Larger Issues for Stevanato Group (NYSE:STVN) Shareholders - Yahoo Finance
Stevanato Group to Present at Upcoming Investor Conferences - The Bakersfield Californian
Stevanato Group to Present at Three Major Healthcare Investor Conferences in Q4 | STVN Stock News - StockTitan
Auto-injectors: syringe-based and cartridge-based autoinjectors - Stevanato Group
Wellington Management Group LLP Bolsters Position in Stevanato G - GuruFocus.com
Stevanato Group S.p.A. Just Missed EarningsBut Analysts Have Updated Their Models - Simply Wall St
Medical devices assembly lines - Stevanato Group
Stevanato Group S.p.A. (NYSE:STVN) Q3 2024 Earnings Call Transcript - Insider Monkey
Citi maintains buy on Stevanato Group with $28 target - Investing.com India
Earnings call: Stevanato Group reports modest growth, eyes future recovery - Investing.com
Stevanato Group Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Customized in-vitro diagnostic consumable - Stevanato Group
In-Vitro Diagnostics (IVD) and Medical Solutions - Stevanato Group
Secondary packaging lines for the pharma industry - Stevanato Group
Drug Delivery systems and solutions - Stevanato Group
Drug containment solutions: Pharmaceutical glass containers - Stevanato Group
Stevanato Group Q3 2024 Earnings Overview - TipRanks
Citi maintains buy on Stevanato Group with $28 target By Investing.com - Investing.com UK
Stevanato Group SpA earnings missed by €0.02, revenue topped estimates - Investing.com
Stevanato Group (STVN) Q3 Earnings Match Estimates - Yahoo Canada Finance
Stevanato: Q3 Earnings Snapshot - San Antonio Express-News
Stevanato Group Reports Financial Results for the Third Quarter of 2024 - The Bakersfield Californian
(STVN) Trading Signals - Stock Traders Daily
What's Next: Stevanato Gr's Earnings Preview - Benzinga
Stevanato Group SpA (STVN) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance
(STVN) On The My Stocks Page - Stock Traders Daily
We Think Stevanato Group (NYSE:STVN) Is Taking Some Risk With Its Debt - Simply Wall St
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024 - Business Wire
Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
nVerses Capital LLC Takes Position in Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Stevanato Group S.p.A.: Expansion & Efficiency In Product Lines & Other Major Drivers - Smartkarma
How the (STVN) price action is used to our Advantage - Stock Traders Daily
Squarepoint Ops LLC Purchases 6,853 Shares of Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Pharmaceutical Visual Inspection Systems Market: Detailed - openPR
The Manufacturers Life Insurance Company Boosts Position in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Check Out Stevanato Group Spa (STVN)’s Trade Data Rather Than the Analysts’ Views - SETE News
Financial Fitness Check: Examining Stevanato Group Spa (STVN)’s Key Ratios - The Dwinnex
Stevanato Group Spa (STVN)’s stock price in review: A technical analysis - US Post News
Stevanato Group Introduces Large-Volume Vertiva On-Body Delivery System - Contract Pharma
Stevanato Group Spa (STVN) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Market Recap Check: Stevanato Group Spa (STVN)’s Negative Finish at 20.00, Up/Down -6.24 - The Dwinnex
Stevanato Group Spa Stock (STVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):